Advantech Capital Ii L.p. - Net Worth and Insider Trading
Advantech Capital Ii L.p. Net Worth
The estimated net worth of Advantech Capital Ii L.p. is at least $221 Million dollars as of 2024-11-11. Advantech Capital Ii L.p. is the of Alphamab Oncology and owns about 49,691,190 shares of Alphamab Oncology (HKSE:09966) stock worth over $221 Million. Details can be seen in Advantech Capital Ii L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advantech Capital Ii L.p. has not made any transactions after 2019-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Advantech Capital Ii L.p.
Advantech Capital Ii L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Advantech Capital Ii L.p. owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .
Click here to see the complete history of Advantech Capital Ii L.p.’s form 4 insider trades.
Insider Ownership Summary of Advantech Capital Ii L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 |
Advantech Capital Ii L.p. Latest Holdings Summary
Advantech Capital Ii L.p. currently owns a total of 1 stock. Advantech Capital Ii L.p. owns 49,691,190 shares of Alphamab Oncology (HKSE:09966) as of December 12, 2019, with a value of $221 Million.
Latest Holdings of Advantech Capital Ii L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 | 49,691,190 | 4.45 | 221,125,796 |
Holding Weightings of Advantech Capital Ii L.p.
Advantech Capital Ii L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Advantech Capital Ii L.p. has made a total of 1 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on December 12, 2019, which brought Advantech Capital Ii L.p. around $0.
Insider Trading History of Advantech Capital Ii L.p.
- 1
Advantech Capital Ii L.p. Trading Performance
Advantech Capital Ii L.p. Ownership Network
Ownership Network List of Advantech Capital Ii L.p.
Ownership Network Relation of Advantech Capital Ii L.p.
Advantech Capital Ii L.p. Owned Company Details
What does Alphamab Oncology do?
Who are the key executives at Alphamab Oncology?
Advantech Capital Ii L.p. is the of Alphamab Oncology. Other key executives at Alphamab Oncology include 2301 Trustee South Dakota Trust Company Llc , 2305 Beneficiary of a trust Xu Ting , and 2307 Founder of a discretionary trust who can infl LIU YANG .
Alphamab Oncology (HKSE:09966) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alphamab Oncology Insider Transactions
Advantech Capital Ii L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Advantech Capital Ii L.p.. Currently GuruFocus does not have mailing address information for Advantech Capital Ii L.p..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
